There's More Good Vaccine News

Oxford-AstraZeneca's COVID-19 vaccine has average effectiveness of 70%
By Evann Gastaldo,  Newser Staff
Posted Nov 23, 2020 12:01 AM CST
There's More Good Vaccine News
In this Thursday, April 23, 2020 file screen grab taken from video issued by Britain's Oxford University, showing a person being injected as part of the first human trials in the UK to test a potential coronavirus vaccine, untaken by Oxford University in England.   (Oxford University Pool via AP, File)

Another COVID-19 vaccine trial is reporting positive news: The vaccine developed by British pharmaceutical company AstraZeneca in collaboration with the University of Oxford is "highly effective" at preventing disease, the pharma giant says in a statement. The vaccine was found to have an average effectiveness of 70%, CNBC reports, with one of the two dosing regimens that were tested having an efficacy rate of 90%. Among those who got the vaccine, no hospitalizations or severe cases of COVID-19 were reported, the AP reports. It's the third vaccine since last week to report heartening results. (More coronavirus stories.)

Get the news faster.
Tap to install our app.
Install the Newser News app
in two easy steps:
1. Tap in your navigation bar.
2. Tap to Add to Home Screen.